GlassScriptPhysician profile
Guy R Voeller
NPI 1124085485
$41,642.48
in general payments reported to CMS, 2019-2025
27 companies · $6,695 in 2025
The $6,695 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $11K · 2021: $2,237 · 2022: $634 · 2023: $968 · 2024: $455 · 2025: $6,695.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,240 · Education: $2,657 · Food and Beverage: $2,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,240.29 |
| Education | $2,657.28 |
| Food and Beverage | $2,220.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $17,257.02 | 2019-2020 | |
| Allergan, INC. | $10,678.38 | 2019-2021 | |
| Intuitive Surgical, INC. | $6,438.56 | 2020-2025 | |
| Heron Therapeutics, INC. | $1,400.00 | 2020 | |
| Gentleman Orthopedic Solutions | $979.95 | 2019 | |
| Medtronic, INC. | $958.64 | 2021-2025 | Ligasure, Signia, Sonicision |
| Medical Device Business Services, INC. | $861.00 | 2019 | |
| Ethicon US, LLC | $851.01 | 2019-2024 | Echelon Circular, Linx Reflux Management System, Echelon Endopath |
| W. L. Gore & Associates, INC. | $755.51 | 2019-2025 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial |
| Asensus Surgical, INC. | $260.01 | 2019 | |
| Covidien LP | $228.45 | 2019 | |
| Somavac Medical Solutions, INC. | $169.34 | 2021-2024 | Somavac 100 Sustained Vacuum System |
| Davol INC. | $168.49 | 2024-2025 | Phasix Mesh, Arista Ah Flexitip |
| Tela Bio, INC. | $157.89 | 2019-2022 | |
| Endogastric Solutions, INC | $133.12 | 2022-2023 | Esophyx |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $94.23 | 2023 | Titan Sgs Standard Gastric Stapler |
| Mallinckrodt Enterprises LLC | $71.95 | 2019 | |
| Boston Scientific Corporation | $60.39 | 2019-2020 | |
| Z-Medica, LLC | $22.55 | 2019 | |
| Sanara Medtech INC. | $20.55 | 2025 | Celleraterx |
| Cumberland Pharmaceuticals, INC. | $16.97 | 2019 | |
| Smith+Nephew, INC. | $16.32 | 2019 | |
| Osiris Therapeutics INC. | $16.23 | 2019 | |
| Innocoll Pharmaceuticals Limited | $13.22 | 2022 | |
| Kerecis Limited | $12.70 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$411,235.25 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Guy Voeller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.